ReviewInternational journal of clinical and experimental medicine2015
Association of serum parathyrine and calcium levels with primary aldosteronism: a meta-analysis.
Review in International journal of clinical and experimental medicine, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed, 7 citations in OpenAlex.
- Renoprotective RAAS inhibition does not affect the association between worse renal function and higher plasma aldosterone levels.BMC nephrology · 2017Trial
- Clinical significance of parathyroid hormone in mineral and glucose metabolism disorders among patients with primary aldosteronism.SAGE open medicine · 2025Article
- Bilateral or Unilateral Aldosterone Hypersecretion and Responsiveness to Therapy Are Associated with Differences in Calcium/Phosphate Homeostasis in Patients with Primary Aldosteronism.Internal medicine (Tokyo, Japan) · 2024Article
- A Rare Aldosterone-Producing Adenoma Detected byFrontiers in endocrinology · 2019Article
- Article
- Managing resistant hypertension: focus on mineralocorticoid-receptor antagonists.Vascular health and risk management · 2017Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Primary aldosteronism (PA) represents major cause of secondary hypertension, strongly associated with high cardiovascular morbidity and mortality. Aldosterone excess may influence mineral homeostasis, through higher urinary calcium (Ca) excretion reducing calcium plasma levels and leading to secondary increase of parathyrine (PTH). The purpose of the present study is to clarify the association of serum PTH and Ca levels with PA using a metaanalysis approach. We searched articles indexed in the PubMed, OVID and Sciencedirect published as of September 2014 that met our predefined criteria. Six articles with 748 subjects from 8 case-control studies were identified. Overall, pooled analysis indicated that subjects with PA had higher serum PTH concentrations and lower Ca levels than controls with essential hypertension (EH) (PTH: SMD = 1.146, 95% CI = [0.774, 1.518]; Ca: SMD = -0.698, 95% CI = [-1.102,-0.294]). Further subgroup analysis stratified by geological location found a similar pattern both in Italy and Austria (Italy: for PTH, SMD = 1.176, 95% CI = [0.758, 1.593], for Ca, SMD = -0.669, 95% CI = [-1.119,-0.219]; Austria: for PTH, SMD = 1.004, 95% CI = [0.359, 1.648], for Ca, SMD = -0.900, 95% CI = [-1.543,-0.257]). In addition, the subgroup analysis stratified by type of Ca measurement also found a similar pattern by spectrophotometry (SMD = -1.078, 95% CI = [-1.532, -0.623]), but not by ion selective electrode (SMD = -0.248, 95% CI = [-0.810, 0.315]). Sensitivity analysis showed that excluding any one study from the pooled analysis did not vary the results substantially. No evidence of publication bias was observed. In conclusion, this meta-analysis supports a significant association of PTH and Ca concentration with PA. Therefore, the high levels of PTH and low Ca concentrations in serum can be used as a variable predictor for PA.
Indexed as
Identifiers
26628945PMC4658834W2195334412What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.